Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jun 15;85(4):993-1000.
doi: 10.1002/jbm.a.31599.

Bisphosphonate binding affinity as assessed by inhibition of carbonated apatite dissolution in vitro

Zachary J Henneman  1 , George H Nancollas, F Hal Ebetino, R Graham G Russell, Roger J Phipps
Affiliations

Bisphosphonate binding affinity as assessed by inhibition of carbonated apatite dissolution in vitro

Zachary J Henneman et al. J Biomed Mater Res A. .

Abstract

Bisphosphonates (BPs), which display a high affinity for calcium phosphate surfaces, are able to selectively target bone mineral, where they are potent inhibitors of osteoclast-mediated bone resorption. The dissolution of synthetic hydroxyapatite (HAP) has been used previously as a model for BP effects on natural bone mineral. The present work examines the influence of BPs on carbonated apatite (CAP), which mimics natural bone more closely than does HAP. Constant composition dissolution experiments were performed at pH 5.50, physiological ionic strength (0.15M) and temperature (37 degrees C). Selected BPs were added at (0.5 x 10(-6)) to (50.0 x 10(-6))M, and adsorption affinity constants, K(L), were calculated from the kinetics data. The BPs showed concentration-dependent inhibition of CAP dissolution, with significant differences in rank order zoledronate > alendronate > risedronate. In contrast, for HAP dissolution at pH 5.50, the differences between the individual BPs were considerably smaller. The extent of CAP dissolution was also dependent on the relative undersaturation, sigma, and CAP dissolution rates increased with increasing carbonate content. These results demonstrate the importance of the presence of carbonate in mediating the dissolution of CAP, and the possible involvement of bone mineral carbonate in observed differences in bone affinities of BPs in clinical use.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Bisphosphonates and their side chains.
Figure 2
Figure 2
SEM micrographs of seed material (a) CAP and (b) HAP.
Figure 3
Figure 3
FTIR spectrum of HAP, B-type CAP, and bone (2 mg sample in 200 mg KBr).
Figure 4
Figure 4
(a) CC dissolution of 3.00% CAP at various relative undersaturations, and (b) ln RC plotted against ln saturation.
Figure 5
Figure 5
Rate of CAP dissolution plotted against % carbonate (σHAP = 0.02, pH = 5.50, 37°C, error bars ≤ 5.0%).
Figure 6
Figure 6
CC dissolution of (a) HAP at σHAP = −0.42 and (b) 7.96% CAP at σHAP = 0.02 (σCAP = −0.44).
Figure 7
Figure 7
(a) CC dissolution of 3.00% CAP in the presence of zoledronate (σHAP = 0.02) and (b) plot of percent inhibition against concentration of zoledronate.
See this image and copyright information in PMC

References

    1. de Jong WF. The mineral components of bones. Recueil des Travaux Chimiques des Pays-Bas et de la Belgique. 1926;45:445–448.
    1. Bigi A, Cojazzi G, Panzavolta S, Ripamonti A, Roveri N, Romanello M, Suarez KN, Moro L. Chemical and structural characterization of the mineral phase from cortical and trabecular bone. J Inorg Biochem. 1997;68:45–51. - PubMed
    1. Astala R, Stott MJ. First principles investigation of mineral component of bone: CO3 substitutions in hydroxyapatite. Chem Mater. 2005;17:4125.
    1. Fleisch H. Bisphosphonates in Bone Disease: From the Laboratory to the Patient. San Diego, CA: Academic Press; 2000.
    1. LeGeros RZ. Calcium Phosphates in Oral Biology and Medicine. New York: Karger; 1991. - PubMed

Publication types

LinkOut - more resources